Text messages to help people with HIV in Vietnam call the quitline and quit smoking
mHealth Messaging to Motivate Quitline use and Quitting among Persons Living With HIV in Vietnam (M2Q2-HIV)
Tailored text messages will encourage people living with HIV in Vietnam to use the national quitline and nicotine replacement to help them stop smoking.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-11180073 on NIH RePORTER |
What this research studies
You would receive personalized SMS messages written with input from people living with HIV that address smoking triggers and HIV-related stigma. The messages are adapted from an existing Vietnamese cessation program and will be further personalized by a machine-learning collective-intelligence system that learns which messages work best. The program aims to connect HIV outpatient clinics with the government quitline and promote available nicotine replacement therapy. Participation would involve receiving texts and being encouraged to call the quitline and access local cessation services.
Who could benefit from this research
Good fit: Adults living with HIV in Vietnam who currently smoke and have access to a mobile phone are the ideal candidates.
Not a fit: People without a mobile phone, living outside Vietnam, or not willing to try quitline support or nicotine replacement are unlikely to benefit.
Why it matters
Potential benefit: If successful, this could increase quitline use and help more people living with HIV in Vietnam quit smoking.
How similar studies have performed: Previous text-message and quitline programs have helped smokers quit, but tailoring messages specifically for people with HIV and using collective-intelligence personalization is relatively new.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Sadasivam, Rajani — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Sadasivam, Rajani
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.